← Leaderboards
Olga Zolochevska Cain
University Of Texas Med Br Galveston
$49,907
Attributed
$49,907
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.1K · FY2017–18$50K$37.5K$25K$12.5K$0
'17
'18
Funding mix
By agency
NIH$49,907 · 1
By mechanism
F31$49,907 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Rakez Kayed$17,147,270
- Wenbo Zhang$11,264,299
- Hua Liu$4,776,133
- Balaji Krishnan$2,730,032
- Larry Denner$1,521,519
Others in their field
Other Emerging Leaders on “Abeta Oligomer”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Mary E Hamby · Cognition Therapeutics, Inc.$9,832,688
- Timothy R Siegert · Allyx Biosciences, Inc.$5,367,450
- Jessica Brooke Langbaum · Banner Health$4,375,233
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$4,054,957
- Andres M Norambuena · University Of Virginia$3,498,906
Research focus
Abeta OligomerAbeta ToxicityAchievementAffectAge RelatedAlzheimer&AposAmyloid Beta-ProteinBindingBiological PreservationBrainCareerCause Of DeathCognitiveCognitive AbilityCognitive FunctionDementedDementiaDensityDesignEffective TherapyElectrophysiology (Science)Enzyme-Linked Immunosorbent AssayEpigenetic ProcessAbeta Accumulation
Grant awards (2)
Epigenetic Modulation of Amyloid Beta-resistant Synapses in Non-demented Subjects with Alzheimer's Neuropathology$17,773
F31 · FY2018 · AG · contact PI
Epigenetic Modulation of Amyloid Beta-resistant Synapses in Non-demented Subjects with Alzheimer's Neuropathology$32,134
F31 · FY2017 · AG · contact PI